118 related articles for article (PubMed ID: 21666343)
1. [Molecular target therapeutics of cancer and translational research].
Shiotsu Y
Nihon Yakurigaku Zasshi; 2011 Jun; 137(6):241-4. PubMed ID: 21666343
[No Abstract] [Full Text] [Related]
2. Are targeted therapies really targeted?
Schilsky RL
Clin Adv Hematol Oncol; 2003 Dec; 1(12):722-3. PubMed ID: 16258475
[No Abstract] [Full Text] [Related]
3. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
[TBL] [Abstract][Full Text] [Related]
4. New Clinical Trial Designs Hasten Approvals for Targeted Therapies.
Schmidt C
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26944760
[No Abstract] [Full Text] [Related]
5. Introduction to the special issue on translational research involving oxidative stress.
Dennery PA
Free Radic Biol Med; 2011 Sep; 51(5):923-4. PubMed ID: 21679766
[No Abstract] [Full Text] [Related]
6. Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back.
Chau NG; Lorch JH
Oncologist; 2015 Jul; 20(7):699-701. PubMed ID: 26040619
[TBL] [Abstract][Full Text] [Related]
7. Translational modeling and simulation approaches for molecularly targeted small molecule anticancer agents from bench to bedside.
Yamazaki S; Spilker ME; Vicini P
Expert Opin Drug Metab Toxicol; 2016; 12(3):253-65. PubMed ID: 26799750
[TBL] [Abstract][Full Text] [Related]
8. Enhancing value of clinical pharmacodynamics in oncology drug development: An alliance between quantitative pharmacology and translational science.
Venkatakrishnan K; Ecsedy JA
Clin Pharmacol Ther; 2017 Jan; 101(1):99-113. PubMed ID: 27804123
[TBL] [Abstract][Full Text] [Related]
9. [Side effects of anticancer treatment and the needs for translational research on toxicity: a clinician's perspective].
Shimizu C
Nihon Yakurigaku Zasshi; 2015 Aug; 146(2):72-5. PubMed ID: 26256743
[No Abstract] [Full Text] [Related]
10. Mechanism-based target identification and drug discovery in cancer research.
Gibbs JB
Science; 2000 Mar; 287(5460):1969-73. PubMed ID: 10720316
[TBL] [Abstract][Full Text] [Related]
11. Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.
Bando H; Takebe N
Jpn J Clin Oncol; 2015 Nov; 45(11):1001-6. PubMed ID: 26423340
[TBL] [Abstract][Full Text] [Related]
12. Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?
Marquet P; Longeray PH; Barlesi F; ; Ameye V; Augé P; Cazeneuve B; Chatelut E; Diaz I; Diviné M; Froguel P; Goni S; Gueyffier F; Hoog-Labouret N; Mourah S; Morin-Surroca M; Perche O; Perin-Dureau F; Pigeon M; Tisseau A; Verstuyft C
Therapie; 2015; 70(1):1-19. PubMed ID: 25679189
[TBL] [Abstract][Full Text] [Related]
13. [Translational medicine].
Antal J; Timár A
Orv Hetil; 2011 Nov; 152(47):1894-902. PubMed ID: 22042316
[TBL] [Abstract][Full Text] [Related]
14. Learning from exceptional drug responders.
Mullard A
Nat Rev Drug Discov; 2014 Jun; 13(6):401-2. PubMed ID: 24875081
[No Abstract] [Full Text] [Related]
15. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
[TBL] [Abstract][Full Text] [Related]
16. A Precision Medicine Approach to Clinical Trials.
Rubin R
JAMA; 2016 Nov; 316(19):1953-1955. PubMed ID: 27760248
[No Abstract] [Full Text] [Related]
17. American Society of Clinical Oncology Developing First Clinical Trial.
Brower V
J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
[No Abstract] [Full Text] [Related]
18. Is target validation all we need?
Frigault MM; Barrett JC
Curr Opin Pharmacol; 2014 Aug; 17():81-6. PubMed ID: 25261632
[TBL] [Abstract][Full Text] [Related]
19. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
20. Molecular targeting therapy for cancer: the Twelfth International Symposium of the Hiroshima Cancer Seminar, November 2002.
Yasui W; Nishiyama M; Tsuruo T; Tahara E
Cancer Sci; 2003 Feb; 94(2):221-3. PubMed ID: 12708501
[No Abstract] [Full Text] [Related]
[Next] [New Search]
